Under the Trump administration, the real estate sector will likely face new circumstances defined by deregulation, leadership changes and tax reforms. While reduced compliance costs and regulatory burdens might pose...more
11/7/2024
/ Advertising ,
Antitrust Provisions ,
Artificial Intelligence ,
Biometric Information ,
China ,
Corporate Taxes ,
Cybersecurity ,
Deregulation ,
Employment Policies ,
Environmental Policies ,
Environmental Social & Governance (ESG) ,
Facial Recognition Technology ,
Federal Trade Commission (FTC) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Independent Contractors ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Investment ,
Joint Employers ,
NLRA ,
Non-Compete Agreements ,
Patents ,
Real Estate Market ,
Retail ,
Tariffs ,
Tax Cuts and Jobs Act ,
Tax Exemptions ,
Technology Sector ,
Tips ,
Tracking Systems ,
Unions ,
USPTO
The UK Court of Appeal has issued its judgment in one of the latest hearings in Neurim Pharmaceuticals v Generics (UK) relating to Neurim’s insomnia drug, Circadin. The Court of Appeal ruled that an exclusive licensee has...more
4/13/2022
/ Appeals ,
Corporate Counsel ,
Exclusivity ,
Intellectual Property Protection ,
IP License ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standing ,
UK
In an important decision impacting life sciences patentees, a divided panel of the Federal Circuit in Barry v. Medtronic, Inc., Appeal No. 2017-2463 (Fed. Cir. January 24, 2019), affirmed a jury’s finding that a doctor was...more
2/2/2019
/ Appeals ,
Experimental Use Exception ,
Inventors ,
Jury Trial ,
Life Sciences ,
Medical Devices ,
On-Sale Bar ,
Patent Applications ,
Patents ,
Physicians ,
Section 102